Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-005699
Filing Date
2024-08-14
Accepted
2024-08-14 16:16:34
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2024 cannapharmarx_i10q-063024.htm   iXBRL 10-Q 928838
2 CERTIFICATION cannapharmarx_ex3101.htm EX-31.1 11658
3 CERTIFICATION cannapharmarx_ex3102.htm EX-31.2 11702
4 CERTIFICATION cannapharmarx_ex3200.htm EX-32 4700
  Complete submission text file 0001683168-24-005699.txt   5090619

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20240630.xsd EX-101.SCH 52112
6 XBRL CALCULATION FILE cpmd-20240630_cal.xml EX-101.CAL 62709
7 XBRL DEFINITION FILE cpmd-20240630_def.xml EX-101.DEF 176066
8 XBRL LABEL FILE cpmd-20240630_lab.xml EX-101.LAB 345581
9 XBRL PRESENTATION FILE cpmd-20240630_pre.xml EX-101.PRE 305141
80 EXTRACTED XBRL INSTANCE DOCUMENT cannapharmarx_i10q-063024_htm.xml XML 671023
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 241208142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)